Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, … Read more
Lumos Diagnostics Holdings Limited (LDXHF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.149x
Based on the latest financial reports, Lumos Diagnostics Holdings Limited (LDXHF) has a cash flow conversion efficiency ratio of 0.149x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($777.97K) by net assets ($5.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lumos Diagnostics Holdings Limited - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Lumos Diagnostics Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lumos Diagnostics Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lumos Diagnostics Holdings Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aman Agrindo
JK:GULA
|
-0.080x |
|
Enduro Metals Corporation
OTCQB:ENDMF
|
-0.023x |
|
Inter-Rock Minerals Inc
PINK:IRCKF
|
0.238x |
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
-20.106x |
|
Odonate Inc.
PINK:ODTCD
|
N/A |
|
Multi Indocitra Tbk
JK:MICE
|
0.034x |
|
Middlesex Water Company PFD 7%
PINK:MSEXP
|
0.044x |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Lumos Diagnostics Holdings Limited (2018–2025)
The table below shows the annual cash flow conversion efficiency of Lumos Diagnostics Holdings Limited from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $6.16 Million | $-9.33 Million | -1.516x | -1239.24% |
| 2024-06-30 | $7.11 Million | $946.00K | 0.133x | +113.11% |
| 2023-06-30 | $9.50 Million | $-9.64 Million | -1.015x | -0.62% |
| 2022-06-30 | $17.89 Million | $-18.04 Million | -1.008x | -439.75% |
| 2021-06-30 | $58.28 Million | $-10.89 Million | -0.187x | -10.16% |
| 2020-06-30 | $22.10 Million | $-3.75 Million | -0.170x | +34.84% |
| 2019-06-30 | $11.65 Million | $-3.03 Million | -0.260x | -168.72% |
| 2018-06-30 | $2.98 Million | $-288.17K | -0.097x | -- |